Search results
Results from the WOW.Com Content Network
Johnson & Johnson management expects operational sales growth between 2.5% and 3.5% in 2025, indicating a strategic focus on consistent mid-point growth. Adjusted operational EPS for 2025 is ...
COVID-19 vaccines gave Moderna, Pfizer and Johnson & Johnson a boost — but are the stocks still a good investment in 2021? Here's what to consider before buying in.
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange.
With the lower re-negotiated a lower price of $21.5 billion between Johnson & Johnson and Guidant, Boston Scientific announced an unsolicited offer of $24.6 billion for Guidant (an offer of $72 per share of Guidant, $36 in cash and a fixed number of Boston Scientific shares valued at $36 a share). 26 2006 Johnson & Johnson: Guidant: 24.2 37
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.
When many investors think of Johnson & Johnson , they tend to think of a slow growth company that draws in income investors with its 5-year average dividend yield of 3.3%. Yet shares of J&J have ...